[PDF][PDF] Hypertension and valsartan

P Kizilirmak, AY Üresin - The Anatolian Journal of Cardiology, 2014 - jag.journalagent.com
Hypertension, which is pointed to be the most frequent cause of death in the World and in
Turkey and defined by the World Health Organization as global health crisis and the …

[PDF][PDF] Valsartan in the treatment of hypertension

S Alajbegovic, A Sukalo, A Alajbegovic, JD Vranic… - Med Arh, 2013 - academia.edu
Hypertension is the most important chronic health problem. It is estimated that hypertension
affects approximately one billion people and that this number will increase by 60% until the …

[PDF][PDF] Renal and metabolic effects of valsartan

T Ecder - The Anatolian Journal of Cardiology, 2014 - jag.journalagent.com
It is known that the drugs which suppress the renin-angiotensin-aldosterone system can
prevent target organ damage, independent of their blood pressure lowering effects. Besides …

Pharmacological and pharmaceutical profile of valsartan: a review

N Siddiqui, A Husain, L Chaudhry, MS Alam… - Journal of Applied …, 2011 - japsonline.com
Angiotensin II Receptor type 1 antagonists have been widely used in treatment of diseases
like hypertension, heart failure, myocardial infarction and diabetic nephropathy. Their …

[PDF][PDF] Valsartan: a brief current review

A Abdullah, MF Rusli - Pharmacophore, 2020 - pharmacophorejournal.com
Hypertension is a multifactorial medical condition which essentially described as persistently
high blood pressure exceeding the normal range of blood pressure which is set at systolic …

Valsartan vs. other angiotensin II receptor blockers in the treatment of hypertension: a meta‐analytical approach

RM Nixon, E Müller, A Lowy… - International journal of …, 2009 - Wiley Online Library
Objective: To compare the efficacy of valsartan in systolic (SBP) and diastolic blood pressure
(DBP) reduction with other angiotensin II receptor blockers (ARBs) in essential hypertension …

Valsartan: more than a decade of experience

HR Black, J Bailey, D Zappe, R Samuel - Drugs, 2009 - Springer
Valsartan is a nonpeptide angiotensin receptor antagonist that selectively blocks the binding
of angiotensin II to the angiotensin II type 1 receptor. The efficacy, tolerability and safety of …

Valsartan: a novel angiotensin type 1 receptor antagonist

PA Thürmann - Expert Opinion on Pharmacotherapy, 2000 - Taylor & Francis
Valsartan is a highly selective, orally available antagonist of the angiotensin Type 1 (AT1)
receptor. It is indicated for treatment of mild to moderate essential hypertension …

Antihypertensive effects of valsartan. National multicentric study

H Prat - Revista Medica de Chile, 2000 - europepmc.org
[Antihypertensive effects of valsartan. National multicentric study]. - Abstract - Europe PMC
Sign in | Create an account https://orcid.org Europe PMC Menu About Tools Developers Help …

Overview of clinical use and side effect profile of valsartan in Chinese hypertensive patients

QF Huang, Y Li, JG Wang - Drug Design, Development and …, 2014 - Taylor & Francis
We reviewed the Chinese and English literature for the efficacy and safety data of valsartan
monotherapy or combination therapy in Chinese hypertensive patients. According to the …